Your browser doesn't support javascript.
loading
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis.
Mertens, Laura S; Claps, Francesco; Mayr, Roman; Hodgson, Anjelica; Shariat, Shahrokh F; Hippe, Katrin; Neuzillet, Yann; Sanders, Joyce; Burger, Maximilian; Pouessel, Damien; Otto, Wolfgang; van der Kwast, Theo H; Lotan, Yair; Allory, Yves; Downes, Michelle R; van Rhijn, Bas W G.
Afiliação
  • Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Claps F; Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Mayr R; Department of Urology, Caritas St Josef Medical Center, 9147University of Regensburg, Regensburg, Germany.
  • Hodgson A; Division of Anatomic Pathology, Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
  • Shariat SF; Department of Laboratory Medicine and Pathobiology, 7938University of Toronto, Toronto, ON, Canada.
  • Hippe K; Department of Pathology, University Health Network, Princess Margaret Cancer Center, 7938University of Toronto, Toronto, ON, Canada.
  • Neuzillet Y; Department of Urology, University of Texas Southwestern Medical center, Dallas, TX, USA.
  • Sanders J; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Burger M; Department of Urology, Weill Cornell Medical College, New York, NY, USA.
  • Pouessel D; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Otto W; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
  • van der Kwast TH; Dept. Pathology, University Medical Center - Regensburg, Regensburg, Germany.
  • Lotan Y; Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Allory Y; Institut Curie, CNRS, UMR144, Molecular Oncology team, PSL Research University, Paris, France.
  • Downes MR; Core Facility Molecular Pathology & Biobank, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • van Rhijn BWG; Department of Urology, Hôpital Foch, UVSQ-Paris-Saclay University, Suresnes, France.
Int J Surg Pathol ; 31(2): 157-166, 2023 Apr.
Article em En | MEDLINE | ID: mdl-35466737
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Proteína Supressora de Tumor p53 Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Proteína Supressora de Tumor p53 Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article